If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Industry Recognition

31 Jan 2006 07:02

Sopheon PLC31 January 2006 Embargoed Release: 07:00hrs Tuesday 31st January 2006 Sopheon Plc ('Sopheon' or the 'Company') Leading IT Market Research Firm Cites Sopheon As First-Mover In Taking Advantage of Major Market Trend New Report Says Company Well-Positioned to Benefit From Convergence of Product Life Cycle and Portfolio Management Solutions Sopheon Plc, the international software and services company, announces todaythat global IT research and advisory firm IDC has published a profile analyzingSopheon and its flagship Accolade process and product portfolio managementsystem. The report credits Sopheon with early recognition of the convergence ofproduct life cycle management (PLM) and project portfolio management (PPM)solutions and taking effective action to capitalize on this trend, which IDCcharacterizes as a major, new market force. (Source: IDC, "Sopheon's AccoladeBreaking out in PLM and Portfolio Management Convergence," Doc #34274.) In an IDC Product Flash, analysts Evan Quinn and Gisela Wilson examine Sopheon'smarket position and the evolution of its flagship offering. From the analysts'perspective, Accolade's functional focus on improving the product developmentprocess, including recent enhancements to the solution, has separated it fromtraditional project portfolio management software and is positively impactingSopheon's business outlook. The report observes that Sopheon seems "particularly well positioned to ride thePLM/PPM convergence trend given its differentiated approach." Earmarks of thatapproach, according to IDC's analysis, include built-in support for the widelyused Stage-Gate(R) product development process framework; portals and analyticstargeted for process industries; integration with Microsoft(R) Project; andstrong portfolio management features. The commentary points to Sopheon'sexpanding sales pipeline, increasing deal size and its stepped-up pursuit ofindirect channel sales partnerships as validation that the company is movinginto a new phase of growth. "Sopheon stands out as a first mover in PLM/PPM convergence," the reportconcludes, "and possesses a position of leverage in Microsoft's businessapplication partnership community. Accolade is ahead of many of its moreestablished competitors in terms of how to leverage collaboration, portal, andcontent technologies for innovation management." "Generic project management tools can provide great value operationally," saidAndy Michuda, chief executive officer of Sopheon, "But they don't address theneeds of corporate executives for information that can help them make strategicproduct-development decisions. There's a growing body of evidence that one ofthe most important characteristics separating innovation leaders from the packis that they put in place a strong product innovation process and support itwith superior project management skills. Accolade enables organizations toquickly develop these capabilities as a sustainable competitive advantage. Oursolution was built from the ground up to manage projects within the businesscontext of the new product development process. And it has demonstrated that itcan produce break-through results. Being recognized as a "first-mover" in thisemerging market of applying project management best-practices to the productlife cycle management process is strong validation of our unique application andstrategic focus. Having this recognition come from one of the world's topindependent IT research and advisory firms is especially affirming." Sopheon Accolade(R) is a registered trademark of Sopheon plc. Stage-Gate(R) is a registered trademark of the Product Development Institute. Microsoft(R) is a registered trademark of Microsoft Corporation.All other trademarks and registered trademarks are the soleproperty of their respective owners. About Sopheon Sopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade(R) product development system automates gate- or phase-basedproduct development processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time-to-market. Sopheon's Monitor software operates as a "readingrobot" that automatically reviews, filters, analyzes and pushes relevant contentto healthcare and engineering professionals to enable effective compliance withprotocols, standards and regulations. Sopheon is listed on the AIM Market of theLondon Stock Exchange and on the Euronext in the Netherlands. For moreinformation, please visit www.sopheon.com. For further information contact: Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.